The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Open accessAbstract
The inherited motor neuron disease spinal muscular atrophy (SMA) is caused by mutation of the telomeric survival motor neuron 1 (SMN1) gene with retention of the centromeric SMN2 gene. We sought to establish whether the potent and specific hydroxamic acid class of histone deacetylase (HDAC) inhibitors activates SMN2 gene expression in vivo and modulates the SMA disease phenotype when delivered after disease onset. Single intraperitoneal doses of 10 mg/kg trichostatin A (TSA) in nontransgenic and SMA model mice resulted in increased levels of acetylated H3 and H4 histones and modest increases in SMN gene expression. Repeated daily doses of TSA caused increases in both SMN2-derived transcript and SMN protein levels in neural tissues and muscle, which were associated with an improvement in small nuclear ribonucleoprotein (snRNP) assembly. When TSA was delivered daily beginning on P5, after the onset of weight loss and motor deficit, there was improved survival, attenuated weight loss, and enhanced motor behavior. Pathological analysis showed increased myofiber size and number and increased anterior horn cell size. These results indicate that the hydroxamic acid class of HDAC inhibitors activates SMN2 gene expression in vivo and has an ameliorating effect on the SMA disease phenotype when administered after disease onset.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Correlation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation
Korzus, E., Rosenfeld, M. G., & Mayford, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.002 · Cited by 823
Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 729
The survival motor neuron protein in spinal muscular atrophy
Coovert, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1205 · Cited by 714
Peripheral nerve regeneration and neurotrophic factors
TERENGHI, G. (1999) · Journal of Anatomy · doi:10.1046/j.1469-7580.1999.19410001.x · Cited by 695
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy
Glass, D. J. (2003) · Nature Cell Biology · doi:10.1038/ncb0203-87 · Cited by 694
International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany)
Munsat, T. L., & Davies, K. E. (1992) · Neuromuscular Disorders · doi:10.1016/s0960-8966(06)80015-5 · Cited by 666
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Rossoll, W., Jablonka, S., Andreassi, C., Kröning, A.-K., Karle, K., Monani, U. R., & Sendtner, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304128 · Cited by 638
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Gui, C.-Y., Ngo, L., Xu, W. S., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550
Essential Role for the SMN Complex in the Specificity of snRNP Assembly
Pellizzoni, L., Yong, J., & Dreyfuss, G. (2002) · Science · doi:10.1126/science.1074962 · Cited by 545
Self-citationUngerstedt, J. S., Sowa, Y., Xu, W.-S., Shao, Y., Dokmanovic, M., Perez, G., Ngo, L., Holmgren, A., Jiang, X., & Marks, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408732102 · Cited by 503
SMN oligomerization defect correlates with spinal muscular atrophy severity
Lorson, C. L., Strasswimmer, J., Yao, J.-M., Baleja, J. D., Hahnen, E., Wirth, B., Le, T., Burghes, A. H. M., & Androphy, E. J. (1998) · Nature Genetics · doi:10.1038/ng0598-63 · Cited by 500
Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.
Pearn, J. (1978) · Journal of Medical Genetics · doi:10.1136/jmg.15.6.409 · Cited by 472
Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse
Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P., & Gilkeson, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16153 · Cited by 408
Treatment of spinal muscular atrophy by sodium butyrate
Chang, J.-G., Hsieh-Li, H.-M., Jong, Y.-J., Wang, N. M., Tsai, C.-H., & Li, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171105098 · Cited by 404
O'Connor, O. A., Heaney, M. L., Schwartz, L., Richardson, S., Willim, R., MacGregor-Cortelli, B., Curly, T., Moskowitz, C., Portlock, C., Horwitz, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9679 · Cited by 404
Muscle-Derived Neurotrophin-4 as an Activity-Dependent Trophic Signal for Adult Motor Neurons
Funakoshi, H., Belluardo, N., Arenas, E., Yamamoto, Y., Casabona, A., Persson, H., & Ibáñez, C. F. (1995) · Science · doi:10.1126/science.7770776 · Cited by 383
Brichta, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg256 · Cited by 382
A new antifungal antibiotic, trichostatin.
TSUJI, N., KOBAYASHI, M., NAGASHIMA, K., WAKISAKA, Y., & KOIZUMI, K. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1 · Cited by 341
Minetti, G. C., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V, Fortuni, S., Straino, S., Sampaolesi, M., Di Padova, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1479 · Cited by 339
Histone deacetylase inhibitors: discovery and development as anticancer agents
Marks, P. A., & Dokmanovic, M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1497 · Cited by 318
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
Sumner, C. J., Huynh, T. N., Markowitz, J. A., Perhac, J. S., Hill, B., Coovert, D. D., Schussler, K., Chen, X., Jarecki, J., Burghes, A. H. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10743 · Cited by 289
Self-citationCamelo, S., Iglesias, A. H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S. G., Imitola, J., Duran, G., Assaf, B., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.022 · Cited by 275
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
Andreassi, C., Angelozzi, C., Tiziano, F. D., Vitali, T., De Vincenzi, E., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201102 · Cited by 255
International SMA consortium meeting
Munsat, T. L. (1992) · Medical Entomology and Zoology · Cited by 243
Iezzi, S., Di Padova, M., Serra, C., Caretti, G., Simone, C., Maklan, E., Minetti, G., Zhao, P., Hoffman, E. P., Puri, P. L., et al. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00107-8 · Cited by 239
Winkler, C., Eggert, C., Gradl, D., Meister, G., Giegerich, M., Wedlich, D., Laggerbauer, B., & Fischer, U. (2005) · Genes & Development · doi:10.1101/gad.342005 · Cited by 230
Neuromuscular defects in a Drosophila survival motor neuron gene mutant
Chan, Y. B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg157 · Cited by 202
Zhang, H., Xing, L., Rossoll, W., Wichterle, H., Singer, R. H., & Bassell, G. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3967-05.2006 · Cited by 200
Wan, L., Battle, D. J., Yong, J., Gubitz, A. K., Kolb, S. J., Wang, J., & Dreyfuss, G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5543-5551.2005 · Cited by 185
Parsons, D. W., McAndrew, P. E., Iannaccone, S. T., Mendell, J. R., Burghes, A. H. M., & Prior, T. W. (1998) · The American Journal of Human Genetics · doi:10.1086/302160 · Cited by 178
Why do cells need an assembly machine for RNA–protein complexes?
Yong, J., Wan, L., & Dreyfuss, G. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.010 · Cited by 167
Carrel, T. L., McWhorter, M. L., Workman, E., Zhang, H., Wolstencroft, E. C., Lorson, C., Bassell, G. J., Burghes, A. H. M., & Beattie, C. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1637-06.2006 · Cited by 165
Cossu, G., & Biressi, S. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.07.003 · Cited by 165
The role of histone acetylation in SMN gene expression
Kernochan, L. E., Russo, M. L., Woodling, N. S., Huynh, T. N., Avila, A. M., Fischbeck, K. H., & Sumner, C. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi130 · Cited by 164
Self-citationLunn, M. R., Root, D. E., Martino, A. M., Flaherty, S. P., Kelley, B. P., Coovert, D. D., Burghes, A. H., thi Man, N., Morris, G. E., Zhou, J., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.024 · Cited by 160
Self-citationJarecki, J., Chen, X., Bernardino, A., Coovert, D. D., Whitney, M., Burghes, A. H. M., Stack, J. H., & Pollok, B. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi205 · Cited by 158
Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints
Warrener, R., Beamish, H., Burgess, A., Waterhouse, N. J., Giles, N., Fairlie, D. P., & Gabrielli, B. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-1003fje · Cited by 149
Castro, L. M. R., Gallant, M., & Niles, L. P. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03457.x · Cited by 118
The molecular bases of spinal muscular atrophy
Frugier, T., Nicole, S., Cifuentes-Díaz, C., & Melki, J. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00301-5 · Cited by 115
Constitutive muscular abnormalities in culture in spinal muscular atrophy
Braun, S., Warter, J., Poindron, P., Croizat, B., & Lagrange, M.-C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90869-2 · Cited by 108
Shafey, D., Côté, P. D., & Kothary, R. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.08.019 · Cited by 107
Gabanella, F., Carissimi, C., Usiello, A., & Pellizzoni, L. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi390 · Cited by 105
Self-citationSMN mRNA and protein levels in peripheral blood: Biomarkers for SMA clinical trials
Sumner, C. J., Kolb, S. J., Harmison, G. G., Jeffries, N. O., Schadt, K. A., Finkel, R. S., Dreyfuss, G., & Fischbeck, K. H. (2006) · Neurology · doi:10.1212/01.wnl.0000201929.56928.13 · Cited by 97
Self-citationTherapeutics development for spinal muscular atrophy
Sumner, C. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.010 · Cited by 97
Self-citationSanderson, L., Taylor, G. W., Aboagye, E. O., Alao, J. P., Latigo, J. R., Coombes, R. C., & Vigushin, D. M. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000638 · Cited by 90
Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients
Arnold, A., Gueye, M., Guettier‐Sigrist, S., Courdier-Fruh, I., Coupin, G., Poindron, P., & Gies, J. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700163 · Cited by 88
Riluzole attenuates spinal muscular atrophy disease progression in a mouse model
Haddad, H., Cifuentes-Díaz, C., Miroglio, A., Roblot, N., Joshi, V., & Melki, J. (2003) · Muscle & Nerve · doi:10.1002/mus.10455 · Cited by 87
Histone Deacetylase Inhibitors: Latest Developments, Trends and Prospects
Moradei, O. M., Maroun, C. R., Paquin, I., & Vaisburg, A. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054866946 · Cited by 84
Challenges and opportunities in clinical trials for spinal muscular atrophy
Hirtz, D., Iannaccone, S. T., Heemskerk, J., Gwinn, K. A., Moxley, R., & Rowland, L. P. (2005) · Neurology · doi:10.1212/01.wnl.0000183282.10946.c7 · Cited by 50
Chapter 2 Pathology of Motor Neuron Disorders
Wharton, S. B., & Ince, P. G. (2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70103-5 · Cited by 22
Cited by
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X.-J., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,230
Lunn, M. R., & Wang, C. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60921-6 · Cited by 995
Matthews, V. B., Åström, M.-B., Chan, M. H. S., Bruce, C. R., Krabbe, K. S., Prelovsek, O., Åkerström, T., Yfanti, C., Broholm, C., Mortensen, O. H., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1364-1 · Cited by 722
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Metadata
- Authors
- Avila, A. M., Burnett, B. G., Taye, A. A., Gabanella, F., Knight, M. A., Hartenstein, P., Cizman, Z., Di Prospero, N. A., Pellizzoni, L., Fischbeck, K. H., & Sumner, C. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 659-671
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1971203455
- Cited by
- 350
- References
- 58
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.